Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason J. Zoeller, Ph.D.

Co-Author

This page shows the publications co-authored by Jason Zoeller and Roderick Bronson.
Connection Strength

0.822
  1. Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer. Breast Cancer Res. 2020 11 30; 22(1):132.
    View in: PubMed
    Score: 0.237
  2. Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo. . 2019 06; 18(6):1115-1126.
    View in: PubMed
    Score: 0.211
  3. Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo. NPJ Breast Cancer. 2017; 3:38.
    View in: PubMed
    Score: 0.190
  4. Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo. NPJ Breast Cancer. 2017; 3:18.
    View in: PubMed
    Score: 0.185
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.